WO2002049574A2 - Procede de traitement de la myopie chez les enfants et adolescents au moyen d'une preparation a base de spiruline - Google Patents

Procede de traitement de la myopie chez les enfants et adolescents au moyen d'une preparation a base de spiruline Download PDF

Info

Publication number
WO2002049574A2
WO2002049574A2 PCT/UA2001/000043 UA0100043W WO0249574A2 WO 2002049574 A2 WO2002049574 A2 WO 2002049574A2 UA 0100043 W UA0100043 W UA 0100043W WO 0249574 A2 WO0249574 A2 WO 0249574A2
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
myopia
treatment
child
spiruline
Prior art date
Application number
PCT/UA2001/000043
Other languages
English (en)
Russian (ru)
Other versions
WO2002049574A3 (fr
Inventor
Lyudmyla Stotska
Original Assignee
Lyudmyla Stotska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lyudmyla Stotska filed Critical Lyudmyla Stotska
Priority to AU2002225588A priority Critical patent/AU2002225588A1/en
Publication of WO2002049574A2 publication Critical patent/WO2002049574A2/fr
Publication of WO2002049574A3 publication Critical patent/WO2002049574A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Definitions

  • the closest to the claimed method is to provide a method of treating myopia and by transmitting biogenic stimulation of aloe.
  • the best one is in the form of injections, ⁇ 1.0 is useful, for 15-20 injections.
  • Medical results a method for treating myopia in children and medical devices with the aid of syrpuline and treatment has been created: treatment of depression; stabilization of myopia; improvement of the vision function (acommodated, invasive system, malignant fatigue); improvement of the metabolic and immunological status of the organism.
  • the above mentioned method cured 40 children and children from 10 to 15 years of weak and moderate degree of myopathy.
  • the analysis of previous and long-term results did not reveal a single complication.
  • the result of distant results (the observation was observed for more than 1 year) showed stabilization of the vision, vision, and irregular system.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Procédé de traitement de la myopie chez les enfants et adolescents au moyen d'une préparation à base de spiruline. L'invention s'utilise en ophtalmologie et permet de traiter la myopie chez les enfants et adolescents au moyen d'une préparation à base de spiruline. Selon l'invention, la préparation à base de spiruline est administrée 3 fois par jour, avec une posologie de 0,5 et 1 g, à usage interne 15-20 minutes avant le repas, per os. Le cycle de traitement dure 1 mois, et un deuxième cycle est prévu 3 mois après le traitement. L'administration de cette préparation permet d'améliorer l'état métabolique et immunologie global de l'organisme ce qui, à son tour, stabilise la myopie et améliore les fonctions visuelles chez les patients souffrant de cette pathologie. Ce procédé permet de 1) prévenir la progression de la myopie, 2) stabiliser la myopie chez les enfants et adolescents et améliorer les fonctions visuelles chez les enfants et adolescents souffrant de myopie.
PCT/UA2001/000043 2000-12-18 2001-11-09 Procede de traitement de la myopie chez les enfants et adolescents au moyen d'une preparation a base de spiruline WO2002049574A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002225588A AU2002225588A1 (en) 2000-12-18 2001-11-09 Method for curing child's and adolescent myopia using a spiruline preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UA2000127273 2000-12-18
UA2000127273A UA40974A (uk) 2000-12-18 2000-12-18 Спосіб лікування міопії у дітей та підлітків

Publications (2)

Publication Number Publication Date
WO2002049574A2 true WO2002049574A2 (fr) 2002-06-27
WO2002049574A3 WO2002049574A3 (fr) 2002-08-01

Family

ID=34391063

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/UA2001/000043 WO2002049574A2 (fr) 2000-12-18 2001-11-09 Procede de traitement de la myopie chez les enfants et adolescents au moyen d'une preparation a base de spiruline

Country Status (3)

Country Link
AU (1) AU2002225588A1 (fr)
UA (1) UA40974A (fr)
WO (1) WO2002049574A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104887927A (zh) * 2015-06-29 2015-09-09 关则钦 一种治疗近视眼的中药制剂及其制备方法
CN104888025A (zh) * 2015-06-29 2015-09-09 关则钦 一种治疗近视眼的中药茶包及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2145228C1 (ru) * 1999-03-23 2000-02-10 Гитлин Исаак Григорьевич Профилактическое и общеукрепляющее средство широкого спектра действия

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2145228C1 (ru) * 1999-03-23 2000-02-10 Гитлин Исаак Григорьевич Профилактическое и общеукрепляющее средство широкого спектра действия

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Federalny Reestr Biologicheski Aktivnykh Dobavok Kpische, M.", 2000, page 199 *
ANNAPURNA, V. V. et al.: "Spirulina as a source of vitamin A", Plant food Hum. Nutr., 1991, Apr., Vol. 41, No. 2 *
MOZHERENKOV, V. P. et al.: "Vitaminy v lechenii glaznykh zabolevany", Meditsinskaya pomosch, 2000, No. 1, pages 44 - 45 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104887927A (zh) * 2015-06-29 2015-09-09 关则钦 一种治疗近视眼的中药制剂及其制备方法
CN104888025A (zh) * 2015-06-29 2015-09-09 关则钦 一种治疗近视眼的中药茶包及其制备方法

Also Published As

Publication number Publication date
AU2002225588A1 (en) 2002-07-01
WO2002049574A3 (fr) 2002-08-01
UA40974A (uk) 2001-08-15

Similar Documents

Publication Publication Date Title
Harris Mucormycosis: Report of a case
WO2002049574A2 (fr) Procede de traitement de la myopie chez les enfants et adolescents au moyen d'une preparation a base de spiruline
Brown Therapeutic experiences with corneal ulcer due to Bacillus pyocyaneus
Löwy Biotherapies of chronic diseases in the inter-war period: from Witte’s peptone to Penicillium extract
RU2602692C1 (ru) Способ лечения хронического фарингита
Ponampalam An unusual case of paralytic ileus after jellyfish envenomation
RU2745328C1 (ru) Способ лечения болевого синдрома при адгезивном капсулите
Buzzard THE TREATMENT OF DISSEMINATED SCLEROSIS: A SUGGESTION.
Temirbulatov et al. Relapse Bullous Emphysema Complicated by Spontaneous Pneumothorax, after Radical Bullectomy
CN1079237C (zh) 犬骨烫伤药
Howell et al. Skin Reactions with B. Typhosus Filtrate.
Doig Epinephrin; especially in asthma
SU1194418A1 (ru) Способ лечени детей с острой гнойной деструктивной пневмонией
RU2129427C1 (ru) Способ лечения заболеваний центральной нервной системы
Hay 210 AUG. 6, 19271 THE-SECTIONS: PRELIMINARY [OTES. r TRRBts
Hay 210 AUG. 6, 19271 THE-SECTIONS: PRELIMINARY [OTES. r TRRBts
Humphreys Sensitivity to Procaine Penicillin
Menzies The Mechanism of Involutionary Melancholia: The Presidential Address at the Annual Meeting of the Medico-Psychological Association of Great Britain and Ireland, held at Buxton on July 26th-28th, 1920
Friel NOTES ON FRIEDLÄNDER'S PNEUMO-BACTERIUM.
RU2306149C2 (ru) Способ лечения больных с затяжной пневмонией с применением препарата "рузам"
Abdel Raheem et al. P-05-012 Safety and effectiveness of collagenase clostridium histolyticum (CCH) in the treatment of Peyronie's disease using a modified protocol
BILLINGS Glandular therapy: introduction
RU2163484C1 (ru) Лекарственное средство и способ коррекции дискинезии желчевыводящей системы и тонкой кишки
Mathewson et al. Blindness from Methyl Alcohol successfully treated by lumbar puncture
Sewall The Importance of Subliminal Symptoms and Period of Alternation of Rest and Exercise in the Treatment of Pulmonary Tuberculosis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP